The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Microsatellite-stable tumors with high tumor mutational burden in association with tumor response to immune checkpoint inhibitor therapy across solid tumors and correlation with specific oncogenic alterations.
 
Imran Nizamuddin
No Relationships to Disclose
 
Peter Doukas
No Relationships to Disclose
 
Pedro Antonio Hermida de Viveiros
No Relationships to Disclose
 
Xinlei Mi
No Relationships to Disclose
 
Neelima Katam
Stock and Other Ownership Interests - Pfizer
 
Young Kwang Chae
Consulting or Advisory Role - AstraZeneca; Biodesix; Boehringer Ingelheim; Counsyl; Foundation Medicine; Guardant Health; Hanmi; Immuneoncia; Lilly; Lunit; Roche/Genentech; Takeda; Tempus
Speakers' Bureau - AstraZeneca; G1 Therapeutics; Genentech/Roche; Jazz Pharmaceuticals; Lilly; Merck
Research Funding - Abbvie; Biodesix; Bristol-Myers Squibb; Freenome; Lexent Bio
Travel, Accommodations, Expenses - Hanmi
 
Amir Behdad
Honoraria - Bayer; Lilly; Roche China; Thermo Fisher Scientific
Speakers' Bureau - Bayer; Lilly; Roche China; Thermofisher Scientific Biomarkers
Travel, Accommodations, Expenses - Bayer; Foundation Medicine; Pfizer
 
Firas Hazem Wehbe
No Relationships to Disclose
 
Devalingam Mahalingam
Consulting or Advisory Role - Amgen; OncoOne
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Eisai; Exelixis; Genentech
Research Funding - Merck KGaA; Oncolytics